Chiropractors in Parlin, NJ Accepting Medicare
8 Chiropractors found. Showing 1 - 8
 Parlin Spine & Disc Llc Chiropractor Medicare: Medicare Enrolled Practice Location: 3010 Bordentown Ave, Suite 2, Parlin, NJ 08859 Phone: 732-721-0044 Fax: 732-316-1336 |
 Dr. Andrew Potash I, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 811 Washington Rd, Parlin, NJ 08859 Phone: 732-238-1883 Fax: 732-238-1890 |
Potash Chiropractic, Pc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 811 Washington Rd, Parlin, NJ 08859 Phone: 732-238-1883 |
Kelly Chiropractic Inc. Chiropractor Medicare: Medicare Enrolled Practice Location: 1 Parkview Blvd, Parlin, NJ 08859 Phone: 732-721-1116 Fax: 732-525-0932 |
Dr. Kevin J Kelly, D.C. Chiropractor Medicare: May Accept Medicare Assignments Practice Location: 1 Parkview Blvd, Parlin, NJ 08859 Phone: 732-721-1116 Fax: 732-525-0932 |
Daniel M Newcomer, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 3010 Bordentown Ave, Sayrebridge Prof Bld, Parlin, NJ 08859 Phone: 732-721-0044 Fax: 732-316-1336 |
Body Wellness & Rehabilitation Llc Chiropractor Medicare: Medicare Enrolled Practice Location: 2909 Washington Rd, Parlin, NJ 08859 Phone: 732-727-5502 Fax: 732-727-5503 |
Dr. John Frank Marullo, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 2909 Washington Rd, Parlin, NJ 08859 Phone: 732-727-5502 Fax: 732-727-5503 |
News Archive
MediciNova starts phase II clinical trial of MN-166 for multiple sclerosis
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
Gilead Sciences presents Phase 3 results of filgotinib in biologic-experienced rheumatoid arthritis at 2018 ACR/ARHP Annual Meeting
Gilead Sciences, Inc. and Galapagos NV today announced detailed results from the Phase 3 FINCH 2 clinical trial of filgotinib, an investigational, selective JAK1 inhibitor, in adults with moderately-to-severely active rheumatoid arthritis and prior inadequate response or intolerance to biologic agents.
Sequencing of human genetic code promises to usher in a new era of genetic medicine
The ability of molecular biologists to sequence the human genetic code promises to usher in a new era of genetic medicine, but that doesn't mean science can accurately read personal genetic codes.
Canadians would welcome HPV vaccine if it were free
Canadians would welcome a vaccine against the human papillomavirus (HPV) if it were introduced at no charge, a Quebec, Canada survey suggests.
JVR special issue focuses on potential of autistic young adults
There has been an explosion of new information on the issues and challenges facing children with autism and their families in the past ten years. However, most coverage ignores the fact that these children grow up. A special issue of the Journal of Vocational Rehabilitation (JVR) focuses on the potential of autistic young adults.
› Verified 8 days ago
Physical Therapists
Chiropractors
Occupational Therapists
Optometrists
Speech-Language Pathologists
Podiatrists